Biotech business Orphazyme, which is based in Copenhagen, Denmark, is planning to raise USD 50m through an American Depositary Shares (ADSs) issuance, it reports in a press release.
The statement also reports that net proceeds from the ADS sales will be spent on the ongoing regulatory approval process for its main candidate arimoclomol, which is a treatment for the neurodegenerative disease, Niemann-Pick disease type C (NPC), in addition to the commercial launch should the drug be approved. The money will also be spent on "general corporate purposes," the press release reads.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Ambu board had started headhunting process long before firing of CEO
Thursday’s CEO change had been in the works for a while, says Ambu’s board chair Jørgen Jensen.
Nine new drugs recommended for approval by CHMP at May meeting
During this month’s meeting of the CHMP, the EMA’s expert committee, a total of nine new drugs have been recommended while six drugs have had indication extensions accepted. Two treatments have been rejected.
Britt Meelby Jensen wants to rebuild trust in Ambu
After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.
Outgoing Ambu CEO commends colleagues
”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.
Top news from MedWatch this week
Miss anything?
Key Account Manager, Europe and Asia 
Laboratory technician for process development and clinical manufacturing 
System Sales Development Consultant - Investment Projects, Merck Millipore 
Analytical Senior Scientist 
Communications Consultant 
2 Sales Representatives and Product Specialists 
Clinical Project Manager 
Senior QA Specialist 
(Senior) Drug Substance Specialist 
Account Manager 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Senior Manager, Clinical Trial Budget 
Vice President, Test & Characterisation 
Nordic Medical Affairs Manager